HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Kirchner Selected Research

Neoplasm Metastasis (Metastasis)

4/2021Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer.
2/2012[Prognostic marker profiles for risk of distant metastases in colorectal cancer].
2/2010[Pathological diagnosis for individualized therapy of colorectal cancer].
1/2007Epithelial-mesenchymal and mesenchymal-epithelial transitions during cancer progression.
8/2001Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment.
1/2000[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Kirchner Research Topics

Disease

29Neoplasms (Cancer)
08/2019 - 01/2000
21Colorectal Neoplasms (Colorectal Cancer)
04/2021 - 01/2000
10Carcinoma (Carcinomatosis)
04/2018 - 01/2000
8Carcinogenesis
01/2017 - 01/2000
6Neoplasm Metastasis (Metastasis)
04/2021 - 01/2000
6Adenoma (Adenomas)
06/2006 - 01/2000
5Gastritis
10/2001 - 03/2000
4Atrophy
02/2001 - 03/2000
3Microsatellite Instability
03/2015 - 03/2003
3Colonic Neoplasms (Colon Cancer)
10/2008 - 01/2000
3Adenocarcinoma
10/2003 - 10/2000
3Infections
05/2003 - 03/2000
2Prostatic Neoplasms (Prostate Cancer)
01/2020 - 07/2015
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2018 - 02/2013
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2016 - 10/2010
2Stomach Neoplasms (Stomach Cancer)
08/2016 - 10/2001
2Breast Neoplasms (Breast Cancer)
03/2013 - 11/2008
2Turcot syndrome
02/2010 - 11/2000
1Urinary Bladder Neoplasms (Bladder Cancer)
03/2020
1Biliary Tract Neoplasms (Biliary Tract Cancer)
08/2019
1Alzheimer Disease (Alzheimer's Disease)
01/2019
1Hepatocellular Carcinoma (Hepatoma)
01/2019
1Ewing Sarcoma (Sarcoma, Ewing)
01/2017
1Genetic Translocation (Chromosomal Translocation)
01/2017
1Margins of Excision
07/2015
1Squamous Cell Carcinoma of Head and Neck
06/2015
1Head and Neck Neoplasms (Head and Neck Cancer)
06/2015
1Squamous Cell Neoplasms (Squamous Cell Cancer)
06/2015
1Sarcoma (Soft Tissue Sarcoma)
11/2014
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
11/2014
1Exanthema (Rash)
02/2013
1Peritoneal Diseases
02/2012
1Appendiceal Neoplasms (Appendix Cancer)
02/2012
1Medullary Carcinoma
02/2010
1Pleomorphic Adenoma
11/2009
1Noninfiltrating Intraductal Carcinoma (DCIS)
11/2009

Drug/Important Bio-Agent (IBA)

10beta CateninIBA
01/2007 - 01/2000
9Biomarkers (Surrogate Marker)IBA
04/2021 - 03/2002
8Proteins (Proteins, Gene)FDA Link
01/2016 - 11/2000
5Cetuximab (Erbitux)FDA Link
11/2019 - 07/2012
4ParaffinIBA
04/2018 - 07/2000
4Fluorouracil (Carac)FDA LinkGeneric
02/2016 - 03/2003
4Oncogene Proteins (Oncogene Protein)IBA
01/2007 - 01/2000
4CollagenIBA
03/2002 - 04/2000
4AutoantibodiesIBA
01/2001 - 03/2000
3Bevacizumab (Avastin)FDA Link
11/2019 - 07/2012
3Leucovorin (Folinic Acid)FDA Link
02/2016 - 03/2003
3Messenger RNA (mRNA)IBA
02/2016 - 08/2001
3Irinotecan (Camptosar)FDA LinkGeneric
02/2016 - 07/2012
3Collagen Type II (Type II Collagen)IBA
03/2002 - 05/2001
2CateninsIBA
04/2021 - 02/2012
2Phosphotransferases (Kinase)IBA
08/2019 - 11/2014
2Formaldehyde (Formol)FDA Link
04/2018 - 06/2011
2AntibodiesIBA
11/2016 - 05/2000
2Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2016 - 09/2014
2MicroRNAs (MicroRNA)IBA
06/2015 - 06/2011
2Codon (Codons)IBA
09/2014 - 08/2012
2ErbB Receptors (EGF Receptor)IBA
02/2013 - 11/2008
2TCF Transcription FactorsIBA
06/2006 - 11/2001
2Metronidazole (Metric)FDA LinkGeneric
05/2003 - 03/2000
2Clarithromycin (Biaxin)FDA LinkGeneric
05/2003 - 03/2000
2Pantoprazole (Protonix)FDA LinkGeneric
05/2003 - 03/2000
2Cyclin D1IBA
11/2001 - 03/2000
2Complement System Proteins (Complement)IBA
10/2001 - 05/2001
2Proteoglycans (Proteoglycan)IBA
08/2001 - 05/2001
2H(+)-K(+)-Exchanging ATPase (Hydrogen, Potassium ATPase)IBA
01/2001 - 03/2000
2AutoantigensIBA
01/2001 - 03/2000
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
03/2020
1Nerve Growth Factor (NGF)IBA
08/2019
1TropomyosinIBA
08/2019
1Amyloid beta-PeptidesIBA
01/2019
1Indicators and Reagents (Reagents)IBA
12/2018
1DNA (Deoxyribonucleic Acid)IBA
04/2018
1EWS-FLI fusion proteinIBA
01/2017
1PD 173074IBA
01/2017
1Transcription Factors (Transcription Factor)IBA
01/2017
1EpiregulinIBA
02/2016
1AmphiregulinIBA
02/2016
1Peptide Initiation Factors (Initiation Factor)IBA
01/2016
1Carcinoembryonic AntigenIBA
01/2016
1Mechanistic Target of Rapamycin Complex 1IBA
01/2016
1Eukaryotic Initiation Factor-4EIBA
01/2016
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2014
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2014
1Tyrosine (L-Tyrosine)FDA Link
11/2014
1Capecitabine (Xeloda)FDA Link
09/2014
1human ERBB2 proteinIBA
03/2013
1Hormones (Hormone)IBA
03/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2013
1Ribonuclease III (RNase III)IBA
06/2011
1Estrogen ReceptorsIBA
11/2008
1Progesterone Receptors (Progesterone Receptor)IBA
11/2008

Therapy/Procedure

15Therapeutics
11/2019 - 07/2000
3Drug Therapy (Chemotherapy)
01/2016 - 03/2003
2Radiotherapy
06/2015 - 11/2000
1Prostatectomy (Retropubic Prostatectomy)
01/2020
1Neoadjuvant Therapy
07/2015
1Aftercare (After-Treatment)
06/2015
1Adjuvant Chemotherapy
02/2010